Dr. Roy's Lab

At UTRGV Biomedical Research Labs, we’re at the forefront of HIV research, developing next-gen anti-HIV drugs with reduced side effects. Our team uses cutting-edge techniques to ensure the efficacy of the drug while prioritizing safety. Through collaboration and community engagement, we’re committed to providing innovative solutions for next-generation treatment for HIV infection and other neurological disorders. Our dedicated researchers are developing advanced genomic and proteomic technologies to identify new drug targets for treatment. By fostering partnerships with leading institutions, we aim to translate our scientific discoveries into practical, life-changing therapies. Our goal is to contribute to the global effort to eradicate HIV and improve the quality of life for those affected by the virus and other associated neurological disorders.

To our groundbreaking work on anti-HIV drugs, our labs are also exploring novel strategies for HIV prevention and vaccine development. Our dedicated researchers are creating advanced genomic and proteomic technologies to identify new targets for intervention for the last twenty years. By fostering partnerships with leading institutions and actively involving the local community in our studies, we aim to translate our scientific discoveries into practical, life-changing therapies. Our goal is to contribute to the global effort to bring next-generation treatment to improve the quality of life for those affected by these diseases.

Dr. Upal Roy

Associate Professor at UTRGV

A Scientist with a strong record of research and development in the field of drug development and drug delivery of infectious disease. Many years of experience in the targeted delivery of drug and vaccine molecule in the preclinical setting. Managed multiple collaboration and work with the multidisciplinary team as principal investigator and associated scientist. Strong interest in mentoring young researcher and their career development. Professional interest includes drug and vaccine development for infectious disease, detection and biomarker development of infection-related neurological disorders.